氟哌利多加入昂丹司琼和地塞米松预防儿童术后呕吐的随机对照双盲研究
结果显示两组24小时内术后呕吐发生率无显著差异(10.5%对11.1%,P=0.86),但加氟哌利多组不良事件更多(8%对2%,P=0.01),主要为嗜睡和头痛。
要点
- 地塞米松联用昂丹司琼加氟哌利多未降低高风险儿童术后呕吐发生率。
- 加氟哌利多组不良事件发生率更高(8%对2%,P=0.01),主要为嗜睡和头痛。
- 推荐对术后呕吐高风险儿童使用地塞米松联用昂丹司琼的两药方案。
核心结论
- 在高风险儿童中,地塞米松、昂丹司琼联用氟哌利多相比两药方案未进一步降低术后呕吐发生率,且增加嗜睡风险。
主要发现
- 术后24小时内术后呕吐总体发生率两组无显著差异:A组16例(10.5%),B组18例(11.1%),P=0.86。
- 不良事件发生率A组2%低于B组8%,P=0.01,主要为嗜睡和头痛。
关键数值与推荐
- 主要结局为术后24小时内术后呕吐发生率,假设加用氟哌利多可额外降低15%的残余风险,但未达到。
- 不良事件为次要结局,A组2%对B组8%,P=0.01。
临床怎么用
- 对术后呕吐高风险儿童,推荐使用地塞米松联用昂丹司琼的两药方案,不加用氟哌利多。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: : The combination of dexamethasone (DEX), ondansetron (OND) and droperidol (DRO) is efficacious in preventing postoperative nausea and vomiting in adults, but has not been well assessed in children. METHODS: : Children undergoing elective surgery under general anaesthesia and considered at high risk for postoperative vomiting (POV) were randomly assigned to receive a combination of DEX, OND and placebo (Group A) or a combination of DEX, OND and DRO (Group B). The primary outcome was the incidence of POV during the first 24 hours after surgery. We hypothesized that the addition of DRO to the standard antiemetic prophylaxis would provide a further 15% reduction in the residual risk for POV. The secondary outcome considered was any adverse event occurring during the study. RESULTS: : One hundred and fifty-three children, aged three to 16 years, were randomized to Group A and 162 to Group B. The overall incidence of POV did not differ significantly between the two groups, with 16 patients in Group A (10.5%) and 18 in Group B (11.1%) presenting with one or more episodes of POV, P =0.86. Fewer patients presented with adverse events in Group A (2%) compared with Group B (8%), P =0.01. Drowsiness and headache were the principal adverse events reported. CONCLUSIONS: : The addition of DRO to a combination of OND and DEX did not decrease POV frequency below that obtained with the two-drug combination in children at high risk of POV, but increased the risk of drowsiness. The combination of DEX and OND should be recommended in children with a high risk of POV. CLINICAL TRIAL REGISTRATION.: NCT01739985.
引用
- Bourdaud N, François C, Jacqmarcq O, et al. Addition of droperidol to prophylactic ondansetron and dexamethasone in children at high risk for postoperative vomiting. A randomized, controlled, double-blind study. Br J Anaesth. 2017. PMID: 28505233. doi:10.1093/bja/aex099
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。